A choledochal cyst is an abnormal, sac-like dilation of the bile ducts, the tubes that carry bile from the liver and gallbladder into the small intestine. These cysts are rare and most often diagnosed in childhood, though roughly one in five cases goes undetected until adulthood. They are far more common in East Asian populations and disproportionately affect females.1Pediatr Surg Int. Choledochal cyst Left untreated, they carry a real risk of serious complications, including cancer of the bile ducts, which is why surgery is recommended for virtually every patient.
What Causes Them
The short answer is that the exact cause remains unclear, but the leading theory centers on a plumbing problem where the pancreatic duct and the bile duct join together. Normally these two ducts meet right at the wall of the duodenum, the first section of the small intestine. In many patients with choledochal cysts, the junction happens much higher up, well outside the intestinal wall. This abnormal arrangement is called an anomalous union of the pancreaticobiliary duct, and it allows pancreatic juice to reflux backward into the bile duct. That backwash of enzymes is thought to weaken and inflame the duct wall over time, leading it to balloon outward.2PubMed Central. Choledochal cyst associated the with anomalous union of pancreaticobiliary duct (AUPBD) has a more grave clinical course than choledochal cyst alone
There is even clinical evidence of this process happening in real time. Researchers documented a case where a six-year-old boy with this abnormal duct junction had a normal-looking bile duct that progressively dilated into a choledochal cyst over an eighteen-month period.3PubMed. Acquired choledochal cyst from anomalous pancreatobiliary duct union That observation strengthened the idea that at least some of these cysts are acquired rather than purely congenital. Still, not every patient with a choledochal cyst has this abnormal duct junction, and not everyone with the junction develops a cyst, so other factors are clearly at play. The strong female predominance and the clustering in East Asian populations suggest a genetic component that researchers have not yet pinned down.
How They Are Classified
Doctors group choledochal cysts using the Todani classification system, which sorts them into five main types based on which part of the biliary system is dilated and what shape the dilation takes. Type I, the most common by far, involves dilation of the main bile duct outside the liver. This type alone accounts for the majority of cases, and it can present as a round sac, a segment-shaped widening, or a more diffuse spindle-shaped enlargement of the duct. Type II is a small pouch that bulges off the side of the bile duct. Type III, sometimes called a choledochocele, is a bulge where the bile duct enters the wall of the duodenum. Type IV involves multiple cysts and comes in two subtypes: IVa affects ducts both inside and outside the liver, while IVb is limited to the extrahepatic ducts. Type V, known as Caroli disease, is dilation of the bile ducts within the liver itself.
This classification is the most widely used system, but it has its limits. There have been numerous reports of cysts that don’t fit neatly into any of the five types.4PubMed Central. The Curious Case of the Choledochal Cyst-Revisiting the Todani Classification: Case Report and Review of the Literature That said, the system remains the standard because it helps surgeons plan the right operation. Type I and type IVa are the ones surgeons encounter most often and that demand the most aggressive approach.
Symptoms in Children Versus Adults
The textbook description of a choledochal cyst includes three symptoms: abdominal pain, jaundice (yellowing of the skin and eyes), and a palpable mass in the upper right abdomen. In practice, that full triad is uncommon, especially in adults.5PubMed Central. Choledochal Cyst in Adults: Etiopathogenesis, Presentation, Management, and Outcome-Case Series and Review Most adults present with abdominal pain and jaundice alone, and many are initially misdiagnosed with gallstones or other more common conditions.
In children, the presentation depends heavily on age. Infants often show jaundice and an abdominal mass but may not be able to communicate pain. Older children tend to report intermittent abdominal pain that comes and goes, sometimes with episodes of jaundice. Some children develop pancreatitis or recurrent infections of the bile ducts (cholangitis) before the cyst is identified.
An increasing number of choledochal cysts are now being picked up before birth on routine prenatal ultrasound. One study followed pregnancies with ultrasound findings suspicious for a choledochal cyst and found that among confirmed cases, about 78% of infants remained free of symptoms through the first year of life, while those with larger cysts (4.5 centimeters or above on initial postnatal ultrasound) were more likely to develop symptoms in the newborn period.6PubMed. The in-utero diagnosis of choledochal cyst: can postnatal imaging predict benefit from early surgical intervention? This prenatal detection creates a window for planning surgery before complications arise.
Adults who present later in life often have a rougher course. A study of adult patients found that half had already undergone previous upper-abdominal operations before being referred to a specialist center, including several who had drainage procedures that ultimately didn’t solve the problem.7PubMed Central. Choledochal cysts in adults and their complications Delayed diagnosis in adults is associated with a higher rate of complications and a greater risk that cancer has already developed by the time the cyst is found.
How the Diagnosis Is Made
Ultrasound is usually the first step. It is inexpensive, widely available, and good at spotting a fluid-filled structure near the bile ducts. In many pediatric cases, ultrasound is enough to raise strong suspicion. But for detailed anatomy, particularly for classifying the type of cyst, mapping the duct anatomy, and checking for complications, magnetic resonance cholangiopancreatography (MRCP) has become the go-to imaging study.
MRCP is a specialized MRI sequence that produces detailed images of the biliary and pancreatic ducts without requiring any contrast injection or radiation. Studies report that MRCP picks up choledochal cysts with a detection rate between 96% and 100%.8PubMed Central. Role of magnetic resonance cholangiopancreatography in diagnosing choledochal cysts: Case series and review It also does a good job identifying the abnormal duct junction described earlier, with accuracy figures around 86% in one study.9Gastrointestinal Endoscopy. Accuracy of magnetic resonance cholangiopancreatography for the diagnosis of choledochal cysts Where MRCP really earns its keep is in detecting complications that change the surgical plan: it catches bile duct stones with near-perfect accuracy and identifies associated bile duct cancers about 87% of the time.10Gastrointestinal Endoscopy. Accuracy of magnetic resonance cholangiopancreatography for the diagnosis of choledochal cysts
The older approach, ERCP (endoscopic retrograde cholangiopancreatography), involves threading a flexible scope down through the mouth and injecting dye directly into the bile ducts. ERCP gives excellent images and can double as a treatment tool for certain problems like removing stones, but it carries risks including pancreatitis. Because MRCP can now provide comparable diagnostic information noninvasively, ERCP has largely been replaced as a first-line diagnostic tool for choledochal cysts. It still has a role when intervention is needed or when MRCP leaves questions unanswered.
The differential diagnosis, meaning what else could look like a choledochal cyst on imaging, includes biliary atresia (especially in newborns), gallstones, pancreatic pseudocysts, liver cysts, and duplication cysts of the intestine. Getting the right diagnosis matters because the treatments for these conditions diverge sharply.
The Cancer Risk
This is the single most important reason choledochal cysts are treated aggressively. Patients with choledochal cysts face a significantly elevated lifetime risk of developing cancer of the bile ducts or gallbladder. A large meta-analysis pooling data on nearly 3,000 patients found that about 11% developed a biliary malignancy, with roughly 7% already harboring cancer at the time of their initial surgery and another 3-4% developing cancer during follow-up.11PubMed Central. Meta-analysis of risk of developing malignancy in congenital choledochal malformation These are striking numbers when you consider that bile duct cancer in the general population is extremely rare.
The risk climbs with age at diagnosis. In one analysis of over 200 patients, being 60 or older at the time of first symptoms was a significant risk factor for having cancer.12PubMed. The risk of carcinogenesis in congenital choledochal cyst patients: an analysis of 214 cases This is part of why surgeons push to operate even on patients whose cysts are not causing symptoms: the longer the cyst sits there, the more years of chronic inflammation the bile duct lining endures, and the higher the chance of malignant transformation.
The type of initial surgery matters enormously. Patients who had their cyst drained but not removed (a procedure called cystoenterostomy, which was more common decades ago) faced a roughly fourfold higher risk of developing biliary cancer compared to those who had the cyst completely excised.13PubMed Central. Meta-analysis of risk of developing malignancy in congenital choledochal malformation A multicenter survey from South Korea reinforced this finding: among patients followed after drainage alone, about 5% developed bile duct cancer, compared with 0.6% after complete excision.14JAMA Surgery. Choledochal Cyst and Associated Malignant Tumors in Adults: A Multicenter Survey in South Korea This evidence is what drove the field to abandon simple drainage in favor of total cyst removal.
Even after complete excision, the cancer risk does not drop to zero. One long-term study found that the cumulative incidence of biliary tract cancer after cyst excision crept up over time, reaching about 4% at twenty years and 11% at twenty-five years after surgery.15PubMed Central. Risk of subsequent biliary malignancy in patients undergoing cyst excision for congenital choledochal cysts The remaining risk likely comes from residual abnormal tissue at the site where the ducts were reconnected and from chronic changes in the intrahepatic ducts that surgery cannot fully address. This residual risk is why lifelong surveillance is recommended after surgery.
Surgery and the Standard Operation
The standard treatment for choledochal cysts is complete surgical excision of the cyst followed by reconstruction of bile flow using a Roux-en-Y hepaticojejunostomy. That means the surgeon removes the dilated portion of the bile duct, then connects the remaining healthy duct directly to a loop of small intestine that has been rerouted for the purpose.16PubMed Central. Robotic assisted excision of type I choledochal cyst with Roux-en-y hepaticojejunostomy reconstruction This approach applies to the most common types, particularly type I and type IVa.17PubMed Central. A choledochal cyst type IVa in a child treated with Roux-en-Y hepaticojejunostomy
Not every type gets the same operation. Type III cysts (choledochoceles) can sometimes be treated with endoscopic unroofing, a much less invasive procedure performed through a scope passed down the throat, where the inner wall of the cyst is cut open to allow free drainage into the intestine.18PubMed. Successful endoscopic unroofing for a pediatric choledochocele Type V (Caroli disease), which involves dilation of the ducts inside the liver, presents a different challenge entirely. If the disease is confined to one lobe, removing that portion of the liver can be curative. When the disease is diffuse across both lobes and leads to recurrent infections, liver failure, or portal hypertension, liver transplantation may be the only option.19PubMed Central. Liver transplantation for caroli disease Long-term data on Caroli disease support the view that liver resection for disease limited to one lobe and transplantation for diffuse disease both produce good survival, but that timely intervention is crucial because of the ongoing risk of life-threatening infection and cancer.20PubMed. Long-term outcome of liver resection and transplantation for Caroli disease and syndrome
Robotic and Laparoscopic Approaches
Open surgery has been the traditional method, but minimally invasive techniques have gained ground quickly, especially in pediatric surgery. Laparoscopic excision (using small incisions and a camera) has been performed for years, and robotic-assisted surgery has entered the picture more recently. The robotic platform gives the surgeon wristed instruments that move with more freedom than standard laparoscopic tools, which can be a real advantage when performing fine work like stitching a tiny bile duct to a loop of intestine in a small child.
A systematic review comparing robotic and laparoscopic surgery for choledochal cysts in children found that the robotic approach was associated with less blood loss during surgery and shorter hospital stays. The rates of postoperative complications like bile leakage, bowel obstruction, and narrowing at the surgical connection trended lower with robotic surgery, though the differences did not reach statistical significance in the pooled analysis.21PubMed. Comparison of efficacy and safety of robotic surgery and laparoscopic surgery for choledochal cyst in children: a systematic review and proportional meta-analysis
Larger single-center studies with more experience have started to show clearer advantages. One center that performed robotic-assisted surgery on 318 children reported a significantly lower overall complication rate compared to their laparoscopic cases, with reduced rates of bile leakage and narrowing at the connection site, as well as fewer reoperations.22PubMed Central. Robot-assisted choledochal cysts resection in children across all ages: a larger cohort single-center experience with 318 Cases Another single-center comparison found that the robotic group had shorter hospital stays and reported zero complications, while the laparoscopic group experienced several, including pancreatitis and wound problems.23PubMed Central. Comparison of laparoscopic and robotic surgery of choledochal cyst in pediatrics: single center experience The trade-off is cost: robotic systems and their disposable instruments are expensive, and the equipment is not available at every hospital. For now, both approaches are reasonable choices when performed by experienced surgeons.
Life After Surgery
Most patients, especially children, do well after choledochal cyst excision. But “do well” and “never have a problem again” are not the same thing. Long-term follow-up data paint a more nuanced picture. One study tracking patients over many years found that about 15% developed late complications, including stones forming inside the liver ducts, infections, and narrowing at the surgical connection. Patients with type IVa cysts, the kind involving both intrahepatic and extrahepatic ducts, had a particularly high rate of trouble, with about 21% experiencing late complications, many of whom needed additional surgery.24PubMed. Long-term outcomes after excision of choledochal cysts in a single institution: operative procedures and late complications
A study focused specifically on type IVa cysts found similar themes: the most common late problems were cholangitis, intrahepatic stones, narrowing of the bile duct connection, and in some cases, shrinkage of a lobe of the liver related to chronic obstruction.25Annals of Hepato-Biliary-Pancreatic Surgery. Long-term complications after extrahepatic cyst excision for type IV-A choledochal cysts The intrahepatic component of type IVa disease is the culprit: surgery removes the extrahepatic cyst, but the dilated ducts inside the liver remain, and they can harbor stagnant bile that breeds infections and stones.
The cancer risk after excision, as discussed earlier, is another reason that follow-up cannot simply stop. Yet adherence to surveillance protocols is poor. One study found that only 44% of patients who were more than five years out from surgery were still being followed, and among those who were, over a third had experienced a major complication.26PubMed Central. Risk of subsequent biliary malignancy in patients undergoing cyst excision for congenital choledochal cysts The message from the surgical literature is consistent: patients need periodic imaging and blood work for years, potentially for life, after the cyst is removed. This is especially true for anyone who had a type IVa cyst, who was older at the time of initial surgery, or who had an abnormal pancreaticobiliary duct junction.
The Role of the Abnormal Duct Junction Beyond the Cyst Itself
The abnormal union of the pancreatic and bile ducts is more than just a possible cause of the cyst. Research suggests it independently worsens the clinical course. A study comparing choledochal cyst patients who had this duct anomaly with those who did not found that the group with the abnormal junction had more serious presentations and complications. The anomaly appears to influence not just the risk of developing the cyst, but also the surgical strategy and the long-term prognosis.27PubMed Central. Choledochal cyst associated the with anomalous union of pancreaticobiliary duct (AUPBD) has a more grave clinical course than choledochal cyst alone
Surgeons care about this junction for a practical reason: if it exists, it needs to be addressed during the operation. The abnormal union essentially creates a channel through which pancreatic enzymes can continue to damage whatever biliary tissue remains after the cyst is removed. Mapping the anatomy with MRCP before surgery helps the surgical team plan how high up the duct needs to be divided and where exactly the new connection to the intestine should be placed. This is one of many reasons why the quality of preoperative imaging directly affects outcomes. In centers with extensive experience, the combination of MRCP mapping and meticulous surgical technique has steadily improved results, but the biology of the disease, particularly in type IVa and type V, still imposes limits on what any operation can achieve.